Aptinyx was founded by Joseph R. Moskal in 2015.

Who are Aptinyx's investors?

Aptinyx's investors include Bain Capital Life Sciences, Frazier Life Sciences, Latterell Venture Partners, Longitude Capital, OUP (Osage University Partners).

How much funding has Aptinyx raised?

Aptinyx has disclosed $95M raised across 2 rounds.

Where is Aptinyx headquartered?

Aptinyx is headquartered in Evanston, US.

Aptinyx

Evanston, US · Founded 2015 · Delaware corporation · 5 known investors

Biotech

Founders & leadership

Aptinyx was founded in 2015 by Joseph R. Moskal.

Joseph R. MoskalChief Scientific Officer

Torsten M. MadsenChief Marketing Officer

Ashish KhannaSecretary & Chief Business Officer

Norbert G. RiedelChief Executive Officer

Board

Liam RatcliffeBoard director

Terry P. GouldBoard director

James N. TopperBoard directorManaging Partner at Frazier Life Sciences

Patrick G. Enright inBoard directorManaging Director at Longitude Capital

Wilbur H. Gantz IIIBoard director

Investors · 5

Bain Capital Life SciencesBostonvia Adam M. Koppel · board

Frazier Life SciencesPalo Altovia James N. Topper · board

Latterell Venture PartnersSan Ramon · $50K – $10M

Longitude CapitalMenlo Park · $10M – $30M

OUP (Osage University Partners)Bala Cynwyd · $1M – $20M

Reported raises · per SEC filings

Form D private placements

$95M disclosed across 2 rounds · 2016–2017

▶$70MraisedDec 2017 · 63 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Joseph R. MoskalExecutive Officer
Terry P. GouldDirector
Andrew D. KiddExecutive Officer
James TopperDirector
Ashish KhannaExecutive Officer
Torsten M. MadsenExecutive Officer
Liam RatcliffeDirector
Adam M. KoppelDirector
Wilbur H. Gantz IIIDirector
Norbert G. RiedelExecutive Officer, Director
Patrick EnrightDirector

Offering amount: $70M
Amount sold: $70M
First sale: Dec 2017
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$25MraisedMay 2016 · 48 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Joseph R. MoskalExecutive Officer
Torsten M. MadsenExecutive Officer
Liam RatcliffeDirector
Ashish KhannaExecutive Officer
Terry P. GouldDirector
Wilbur H. Gantz IIIDirector
James N. TopperDirector
Patrick G. EnrightDirector
Norbert G. RiedelExecutive Officer, Director

Offering amount: $65M
Amount sold: $25M
First sale: May 2016
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2016	$2.3M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2016	$311.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Aptinyx?: Aptinyx was founded by Joseph R. Moskal in 2015.
Who are Aptinyx's investors?: Aptinyx's investors include Bain Capital Life Sciences, Frazier Life Sciences, Latterell Venture Partners, Longitude Capital, OUP (Osage University Partners).
How much funding has Aptinyx raised?: Aptinyx has disclosed $95M raised across 2 rounds.
Where is Aptinyx headquartered?: Aptinyx is headquartered in Evanston, US.